The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Factor VIII Deficiency Treatment Market Research Report 2025

Global Factor VIII Deficiency Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1921521

No of Pages : 94

Ask Your Query
Synopsis
Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endothelial cells outside the liver across the body. This protein mixes in the bloodstream in an inactive form, and binds to another molecule called von Willebrand factor, until a damage to blood vessels occur. In response to injury, coagulation factor VIII gets activated and separates from von Willebrand factor.
The global Factor VIII Deficiency Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global hemophilia A drugs market segment accounted for the majority market share and will continue to dominate the factor 8 deficiency treatment market for the next few years. Some of the major factors responsible for the market segment's growth is the growing incidence of hemophilia A, the development of novel drugs with extended action, and the increased adoption of prophylactic treatment. Additionally, growing demand for novel recombinant extended half-life products, the emergence of monoclonal antibodies and gene therapy products, and launch of plasma-derived products for recombinant factor VIII at low costs, will also further drive the growth of the factor VIII deficiency treatment market.
This report aims to provide a comprehensive presentation of the global market for Factor VIII Deficiency Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Factor VIII Deficiency Treatment.
Report Scope
The Factor VIII Deficiency Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Factor VIII Deficiency Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Factor VIII Deficiency Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Takeda
Bayer HealthCare
CSL
Grifols
Novo Nordisk
F. Hoffmann-La Roche
Kedrion
Octapharma
Biogen Idec
BioMarin Pharmaceutical
Sangamo Therapeutics
Spark Therapeutics
Swedish Orphan Biovitrum
Uniqure NV
Amarna Therapeutics
Dimension Therapeutics
Segment by Type
Hemophilia A Drugs
Hemophilia A Inhibitors Treatment
Von Willebrand Disease Treatment
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Factor VIII Deficiency Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hemophilia A Drugs
1.2.3 Hemophilia A Inhibitors Treatment
1.2.4 Von Willebrand Disease Treatment
1.3 Market by Application
1.3.1 Global Factor VIII Deficiency Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Factor VIII Deficiency Treatment Market Perspective (2019-2030)
2.2 Factor VIII Deficiency Treatment Growth Trends by Region
2.2.1 Global Factor VIII Deficiency Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Factor VIII Deficiency Treatment Historic Market Size by Region (2019-2024)
2.2.3 Factor VIII Deficiency Treatment Forecasted Market Size by Region (2025-2030)
2.3 Factor VIII Deficiency Treatment Market Dynamics
2.3.1 Factor VIII Deficiency Treatment Industry Trends
2.3.2 Factor VIII Deficiency Treatment Market Drivers
2.3.3 Factor VIII Deficiency Treatment Market Challenges
2.3.4 Factor VIII Deficiency Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Factor VIII Deficiency Treatment Players by Revenue
3.1.1 Global Top Factor VIII Deficiency Treatment Players by Revenue (2019-2024)
3.1.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Factor VIII Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Factor VIII Deficiency Treatment Revenue
3.4 Global Factor VIII Deficiency Treatment Market Concentration Ratio
3.4.1 Global Factor VIII Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Factor VIII Deficiency Treatment Revenue in 2023
3.5 Factor VIII Deficiency Treatment Key Players Head office and Area Served
3.6 Key Players Factor VIII Deficiency Treatment Product Solution and Service
3.7 Date of Enter into Factor VIII Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Factor VIII Deficiency Treatment Breakdown Data by Type
4.1 Global Factor VIII Deficiency Treatment Historic Market Size by Type (2019-2024)
4.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2025-2030)
5 Factor VIII Deficiency Treatment Breakdown Data by Application
5.1 Global Factor VIII Deficiency Treatment Historic Market Size by Application (2019-2024)
5.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Factor VIII Deficiency Treatment Market Size (2019-2030)
6.2 North America Factor VIII Deficiency Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Factor VIII Deficiency Treatment Market Size by Country (2019-2024)
6.4 North America Factor VIII Deficiency Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Factor VIII Deficiency Treatment Market Size (2019-2030)
7.2 Europe Factor VIII Deficiency Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Factor VIII Deficiency Treatment Market Size by Country (2019-2024)
7.4 Europe Factor VIII Deficiency Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size (2019-2030)
8.2 Asia-Pacific Factor VIII Deficiency Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Factor VIII Deficiency Treatment Market Size (2019-2030)
9.2 Latin America Factor VIII Deficiency Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Factor VIII Deficiency Treatment Market Size by Country (2019-2024)
9.4 Latin America Factor VIII Deficiency Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size (2019-2030)
10.2 Middle East & Africa Factor VIII Deficiency Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Factor VIII Deficiency Treatment Introduction
11.1.4 Pfizer Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Takeda
11.2.1 Takeda Company Detail
11.2.2 Takeda Business Overview
11.2.3 Takeda Factor VIII Deficiency Treatment Introduction
11.2.4 Takeda Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.2.5 Takeda Recent Development
11.3 Bayer HealthCare
11.3.1 Bayer HealthCare Company Detail
11.3.2 Bayer HealthCare Business Overview
11.3.3 Bayer HealthCare Factor VIII Deficiency Treatment Introduction
11.3.4 Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.3.5 Bayer HealthCare Recent Development
11.4 CSL
11.4.1 CSL Company Detail
11.4.2 CSL Business Overview
11.4.3 CSL Factor VIII Deficiency Treatment Introduction
11.4.4 CSL Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.4.5 CSL Recent Development
11.5 Grifols
11.5.1 Grifols Company Detail
11.5.2 Grifols Business Overview
11.5.3 Grifols Factor VIII Deficiency Treatment Introduction
11.5.4 Grifols Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.5.5 Grifols Recent Development
11.6 Novo Nordisk
11.6.1 Novo Nordisk Company Detail
11.6.2 Novo Nordisk Business Overview
11.6.3 Novo Nordisk Factor VIII Deficiency Treatment Introduction
11.6.4 Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.6.5 Novo Nordisk Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Detail
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 Kedrion
11.8.1 Kedrion Company Detail
11.8.2 Kedrion Business Overview
11.8.3 Kedrion Factor VIII Deficiency Treatment Introduction
11.8.4 Kedrion Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.8.5 Kedrion Recent Development
11.9 Octapharma
11.9.1 Octapharma Company Detail
11.9.2 Octapharma Business Overview
11.9.3 Octapharma Factor VIII Deficiency Treatment Introduction
11.9.4 Octapharma Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.9.5 Octapharma Recent Development
11.10 Biogen Idec
11.10.1 Biogen Idec Company Detail
11.10.2 Biogen Idec Business Overview
11.10.3 Biogen Idec Factor VIII Deficiency Treatment Introduction
11.10.4 Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.10.5 Biogen Idec Recent Development
11.11 BioMarin Pharmaceutical
11.11.1 BioMarin Pharmaceutical Company Detail
11.11.2 BioMarin Pharmaceutical Business Overview
11.11.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Introduction
11.11.4 BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.11.5 BioMarin Pharmaceutical Recent Development
11.12 Sangamo Therapeutics
11.12.1 Sangamo Therapeutics Company Detail
11.12.2 Sangamo Therapeutics Business Overview
11.12.3 Sangamo Therapeutics Factor VIII Deficiency Treatment Introduction
11.12.4 Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.12.5 Sangamo Therapeutics Recent Development
11.13 Spark Therapeutics
11.13.1 Spark Therapeutics Company Detail
11.13.2 Spark Therapeutics Business Overview
11.13.3 Spark Therapeutics Factor VIII Deficiency Treatment Introduction
11.13.4 Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.13.5 Spark Therapeutics Recent Development
11.14 Swedish Orphan Biovitrum
11.14.1 Swedish Orphan Biovitrum Company Detail
11.14.2 Swedish Orphan Biovitrum Business Overview
11.14.3 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Introduction
11.14.4 Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.14.5 Swedish Orphan Biovitrum Recent Development
11.15 Uniqure NV
11.15.1 Uniqure NV Company Detail
11.15.2 Uniqure NV Business Overview
11.15.3 Uniqure NV Factor VIII Deficiency Treatment Introduction
11.15.4 Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.15.5 Uniqure NV Recent Development
11.16 Amarna Therapeutics
11.16.1 Amarna Therapeutics Company Detail
11.16.2 Amarna Therapeutics Business Overview
11.16.3 Amarna Therapeutics Factor VIII Deficiency Treatment Introduction
11.16.4 Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.16.5 Amarna Therapeutics Recent Development
11.17 Dimension Therapeutics
11.17.1 Dimension Therapeutics Company Detail
11.17.2 Dimension Therapeutics Business Overview
11.17.3 Dimension Therapeutics Factor VIII Deficiency Treatment Introduction
11.17.4 Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024)
11.17.5 Dimension Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hemophilia A Drugs
Table 3. Key Players of Hemophilia A Inhibitors Treatment
Table 4. Key Players of Von Willebrand Disease Treatment
Table 5. Global Factor VIII Deficiency Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Factor VIII Deficiency Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Factor VIII Deficiency Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Factor VIII Deficiency Treatment Market Share by Region (2019-2024)
Table 9. Global Factor VIII Deficiency Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Factor VIII Deficiency Treatment Market Share by Region (2025-2030)
Table 11. Factor VIII Deficiency Treatment Market Trends
Table 12. Factor VIII Deficiency Treatment Market Drivers
Table 13. Factor VIII Deficiency Treatment Market Challenges
Table 14. Factor VIII Deficiency Treatment Market Restraints
Table 15. Global Factor VIII Deficiency Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Factor VIII Deficiency Treatment Market Share by Players (2019-2024)
Table 17. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor VIII Deficiency Treatment as of 2023)
Table 18. Ranking of Global Top Factor VIII Deficiency Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Factor VIII Deficiency Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Factor VIII Deficiency Treatment Product Solution and Service
Table 22. Date of Enter into Factor VIII Deficiency Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Factor VIII Deficiency Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global Factor VIII Deficiency Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America Factor VIII Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Factor VIII Deficiency Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Factor VIII Deficiency Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Factor VIII Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Factor VIII Deficiency Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Factor VIII Deficiency Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Factor VIII Deficiency Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Factor VIII Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Factor VIII Deficiency Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Factor VIII Deficiency Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Factor VIII Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Pfizer Company Detail
Table 48. Pfizer Business Overview
Table 49. Pfizer Factor VIII Deficiency Treatment Product
Table 50. Pfizer Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Takeda Company Detail
Table 53. Takeda Business Overview
Table 54. Takeda Factor VIII Deficiency Treatment Product
Table 55. Takeda Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 56. Takeda Recent Development
Table 57. Bayer HealthCare Company Detail
Table 58. Bayer HealthCare Business Overview
Table 59. Bayer HealthCare Factor VIII Deficiency Treatment Product
Table 60. Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 61. Bayer HealthCare Recent Development
Table 62. CSL Company Detail
Table 63. CSL Business Overview
Table 64. CSL Factor VIII Deficiency Treatment Product
Table 65. CSL Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 66. CSL Recent Development
Table 67. Grifols Company Detail
Table 68. Grifols Business Overview
Table 69. Grifols Factor VIII Deficiency Treatment Product
Table 70. Grifols Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 71. Grifols Recent Development
Table 72. Novo Nordisk Company Detail
Table 73. Novo Nordisk Business Overview
Table 74. Novo Nordisk Factor VIII Deficiency Treatment Product
Table 75. Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 76. Novo Nordisk Recent Development
Table 77. F. Hoffmann-La Roche Company Detail
Table 78. F. Hoffmann-La Roche Business Overview
Table 79. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Product
Table 80. F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 81. F. Hoffmann-La Roche Recent Development
Table 82. Kedrion Company Detail
Table 83. Kedrion Business Overview
Table 84. Kedrion Factor VIII Deficiency Treatment Product
Table 85. Kedrion Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 86. Kedrion Recent Development
Table 87. Octapharma Company Detail
Table 88. Octapharma Business Overview
Table 89. Octapharma Factor VIII Deficiency Treatment Product
Table 90. Octapharma Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 91. Octapharma Recent Development
Table 92. Biogen Idec Company Detail
Table 93. Biogen Idec Business Overview
Table 94. Biogen Idec Factor VIII Deficiency Treatment Product
Table 95. Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 96. Biogen Idec Recent Development
Table 97. BioMarin Pharmaceutical Company Detail
Table 98. BioMarin Pharmaceutical Business Overview
Table 99. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product
Table 100. BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 101. BioMarin Pharmaceutical Recent Development
Table 102. Sangamo Therapeutics Company Detail
Table 103. Sangamo Therapeutics Business Overview
Table 104. Sangamo Therapeutics Factor VIII Deficiency Treatment Product
Table 105. Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 106. Sangamo Therapeutics Recent Development
Table 107. Spark Therapeutics Company Detail
Table 108. Spark Therapeutics Business Overview
Table 109. Spark Therapeutics Factor VIII Deficiency Treatment Product
Table 110. Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 111. Spark Therapeutics Recent Development
Table 112. Swedish Orphan Biovitrum Company Detail
Table 113. Swedish Orphan Biovitrum Business Overview
Table 114. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product
Table 115. Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 116. Swedish Orphan Biovitrum Recent Development
Table 117. Uniqure NV Company Detail
Table 118. Uniqure NV Business Overview
Table 119. Uniqure NV Factor VIII Deficiency Treatment Product
Table 120. Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 121. Uniqure NV Recent Development
Table 122. Amarna Therapeutics Company Detail
Table 123. Amarna Therapeutics Business Overview
Table 124. Amarna Therapeutics Factor VIII Deficiency Treatment Product
Table 125. Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 126. Amarna Therapeutics Recent Development
Table 127. Dimension Therapeutics Company Detail
Table 128. Dimension Therapeutics Business Overview
Table 129. Dimension Therapeutics Factor VIII Deficiency Treatment Product
Table 130. Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 131. Dimension Therapeutics Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Factor VIII Deficiency Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Factor VIII Deficiency Treatment Market Share by Type: 2023 VS 2030
Figure 3. Hemophilia A Drugs Features
Figure 4. Hemophilia A Inhibitors Treatment Features
Figure 5. Von Willebrand Disease Treatment Features
Figure 6. Global Factor VIII Deficiency Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Factor VIII Deficiency Treatment Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Factor VIII Deficiency Treatment Report Years Considered
Figure 12. Global Factor VIII Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Factor VIII Deficiency Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Factor VIII Deficiency Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Factor VIII Deficiency Treatment Market Share by Players in 2023
Figure 16. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor VIII Deficiency Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Factor VIII Deficiency Treatment Revenue in 2023
Figure 18. North America Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Factor VIII Deficiency Treatment Market Share by Country (2019-2030)
Figure 20. United States Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Factor VIII Deficiency Treatment Market Share by Country (2019-2030)
Figure 24. Germany Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Factor VIII Deficiency Treatment Market Share by Region (2019-2030)
Figure 32. China Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Factor VIII Deficiency Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Factor VIII Deficiency Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Factor VIII Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 47. Takeda Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 48. Bayer HealthCare Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 49. CSL Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 50. Grifols Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 51. Novo Nordisk Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 52. F. Hoffmann-La Roche Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 53. Kedrion Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 54. Octapharma Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 55. Biogen Idec Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 56. BioMarin Pharmaceutical Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 57. Sangamo Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 58. Spark Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 59. Swedish Orphan Biovitrum Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 60. Uniqure NV Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 61. Amarna Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 62. Dimension Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock